AGAP2 and non-small cell lung carcinoma: These findings are accordant with the study conducted by Li et al., which revealed that increased levels of AGAP2-AS1 were observed to stimulate the proliferation, migration, and invasion of NSCLC cells while inhibiting their apoptosis.